Defence Therapeutics Inc.

CNSX:DTC ISIN:CA24463V1013

Located in Quebec, Canada, the Defence Therapeutics Inc. (CNSX:DTC) (FRA:DTC) (OTCMKTS:DTCFF) leadership team brings extensive experience in the capital markets, finance, biochemistry, pharmacology, biotech, immunology. Together they have developed the company's IP and are leading the current product pipeline.

 
 

News

Ellis Martin Report: Defence Therapeutics Inc. (CNSX:DTC) Dr. Moutih Rafei-Developing Vaccines and Platform Technologies for the Treatment of Cancer

🕔6/12/2024 10:47:17 AM 2935

Join Ellis Martin and Money Talk Radio for a conversation with Dr. Moutih Rafei, Chief Science Officer of Defence Therapeutics (CNSX:DTC) (FRA:DTC) (OTCMKTS:DTCFF).

Read Full Article
###

361 COMPANY PROFILE VIEWS

  • This Page Viewed: (Last 7 Days: 15) (Last 30 Days: 77) (Since Published: 361) 

Company Data

    Headquarters
  • 1680 – 200 Burrard Street
    Vancouver, BC, V6C 3L6
    Canada
  • Principal Sector
  • Biotech 
  • Principal Industry
  • Healthcare 
  • Homepage
  • www.defencetherapeutics.com/